The only problem: the effects dont last very long
If prescribed, medication is compounded and shipped in discreet, temperature-controlled packaging
The impact of GLP-1 RAs on mortality, MACEs, and MAKEs The crude incidence of mortality rate was 22.91 per 1000 person-years, which was significantly lower in the GLP-1 RAs users group than in the non-users group (6.8% vs
While not direct drug side effects, these changes occur in the context of treatment and may be perceived as medication-related
Long-acting GLP1-RA have many favorable properties and have clear efficacy data for reducing cardiovascular risks, as well as safety data, for their use in patients with T2D at high cardiovascular risk, including the subset of patients with DKD